Under the agreement, H. pylori medication Talicia will not require prior authorization and will have a $0 copay for Medi-Cal patients, according to an Oct. 1 press release.
Talicia has been listed by Medi-Cal since 2021, making it available to 15 million Californian patients.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
